狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            產(chǎn)品推薦:氣相|液相|光譜|質(zhì)譜|電化學(xué)|元素分析|水分測定儀|樣品前處理|試驗機(jī)|培養(yǎng)箱


            化工儀器網(wǎng)>技術(shù)中心>技術(shù)參數(shù)>正文

            歡迎聯(lián)系我

            有什么可以幫您? 在線咨詢

            NIBSC

            來源:深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司   2017年05月09日 15:15  

                   英國國家生物制品檢定所NIBSC是WHO的一個標(biāo)準(zhǔn)品供應(yīng)中心實驗室,它的核心工作是制備、保存和分發(fā)WHO用于檢測生物制品質(zhì)量的標(biāo)準(zhǔn)品。

                  NIBSC 戰(zhàn)略目標(biāo):對有關(guān)生物產(chǎn)品的問題給出回復(fù)和建議;提供生物藥品方面的國家科技力量,維持滿足科學(xué)和藥物學(xué)領(lǐng)域新發(fā)展需求的靈活性、專業(yè)知識和設(shè)施;

             

             

                    深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司經(jīng)銷EP,USP,LGCTRC,TLC,MOLCAN藥物標(biāo)準(zhǔn)品,NIBSC英國國家生物制品檢定所標(biāo)準(zhǔn)試劑法國Extrasynthese中草藥標(biāo)準(zhǔn)品,WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品,NIST美國國家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品,IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品,CIL美國劍橋同位素標(biāo)準(zhǔn)品,種類齊全,到貨迅速。

             

            請點擊本頁標(biāo)題下方“進(jìn)入該公司展臺” 查看我司信息。

            (何:;phastandards;: )

             

            標(biāo)準(zhǔn)品部分產(chǎn)品列表:

            01/522

            Meningococcal serogroup W polysaccharide

            03/104-029

            HTLV-14 (antibody) Monitor Sample

            10/128

            Reteplase Reference Material

            13/243

            C-Peptide, Human. 98st International Standard.

            13/213

            Influenza Antigen B/Massachusetts/02/2091 (Egg derived)

            13/212

            Influenza Antigen B/Massachusetts/02/2090 (Egg derived)

            10/125

            Reteplase Reference Material

            13/240

            Polio Anti Sabin type 23 (inactivated) Serum

            03/104-089

            HTLV-74 (antibody) Monitor Sample

            13/254

            Polio Anti Sabin type 37 (inactivated) Serum

            10/152

            Reteplase Reference Material

            10/155

            Reteplase Reference Material

            03/104-027

            HTLV-12 (antibody) Monitor Sample

            07/344

            BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent)

            12/B623-086

            QCRFLUAH1N1QC1-Influenza AH1N1 QC84

            95/631

            Interleukin-92 (Human, rDNA derived)

            13/224

            C-Peptide, Human. 79st International Standard.

            95/650

            Interleukin-111 (Human, rDNA derived)

            01/431

            Meningococcal serogroup W polysaccharide

            10/120

            Reteplase Reference Material

            13/305

            Polio Anti Sabin type 88 (inactivated) Serum

            95/556

            Interleukin-17 (Human, rDNA derived)

            13/227

            Influenza Antigen B/Massachusetts/02/2105 (Egg derived)

            10/197

            Reteplase Reference Material

            10/205

            Reteplase Reference Material

            03/104-046

            HTLV-31 (antibody) Monitor Sample

            03/104-065

            HTLV-50 (antibody) Monitor Sample

            13/316

            Polio Anti Sabin type 99 (inactivated) Serum

            13/288

            Polio Anti Sabin type 71 (inactivated) Serum

            12/B623-037

            QCRFLUAH1N1QC1-Influenza AH1N1 QC35

            07/375

            BCG Vaccine of Russian BCG-I sub-strain(102st WHO Reference Reagent)

            95/606

            Interleukin-67 (Human, rDNA derived)

            13/199

            C-Peptide, Human. 54st International Standard.

            07/296

            BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent)

            03/104-114

            HTLV-99 (antibody) Monitor Sample

            13/242

            C-Peptide, Human. 97st International Standard.

            13/139

            Influenza Antigen B/Massachusetts/02/2017 (Egg derived)

            12/B623-087

            QCRFLUAH1N1QC1-Influenza AH1N1 QC85

            03/104-030

            HTLV-15 (antibody) Monitor Sample

            13/208

            C-Peptide, Human. 63st International Standard.

            07/298

            BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent)

            13/160

            Influenza Antigen B/Massachusetts/02/2038 (Egg derived)

            10/196

            Reteplase Reference Material

            13/229

            Influenza Antigen B/Massachusetts/02/2107 (Egg derived)

            01/508

            Meningococcal serogroup W polysaccharide

            13/223

            Influenza Antigen B/Massachusetts/02/2101 (Egg derived)

            95/574

            Interleukin-35 (Human, rDNA derived)

            13/307

            Polio Anti Sabin type 90 (inactivated) Serum

            12/B623-020

            QCRFLUAH1N1QC1-Influenza AH1N1 QC18

            10/192

            Reteplase Reference Material

            10/165

            Reteplase Reference Material

            01/465

            Meningococcal serogroup W polysaccharide

            01/435

            Meningococcal serogroup W polysaccharide

            13/251

            Polio Anti Sabin type 34 (inactivated) Serum

            13/263

            Polio Anti Sabin type 46 (inactivated) Serum

            01/497

            Meningococcal serogroup W polysaccharide

            13/286

            Polio Anti Sabin type 69 (inactivated) Serum

            13/148

            C-Peptide, Human. 3st International Standard.

            07/347

            BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent)

            13/146

            Influenza Antigen B/Massachusetts/02/2024 (Egg derived)

             

            免責(zé)聲明

            • 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
            • 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負(fù)版權(quán)等法律責(zé)任。
            • 如涉及作品內(nèi)容、版權(quán)等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。
            企業(yè)未開通此功能
            詳詢客服 : 0571-87858618